Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2000 1
2001 3
2002 3
2003 1
2004 2
2005 7
2006 5
2007 6
2008 4
2009 9
2010 9
2011 10
2012 13
2013 7
2014 15
2015 14
2016 25
2017 22
2018 38
2019 34
2020 41
2021 18
Text availability
Article attribute
Article type
Publication date

Search Results

260 results
Results by year
Filters applied: . Clear all
Page 1
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlhäufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crinò L, Blumenschein GR Jr, Antonia SJ, Dorange C, Harbison CT, Graf Finckenstein F, Brahmer JR. Borghaei H, et al. Among authors: arrieta o. N Engl J Med. 2015 Oct 22;373(17):1627-39. doi: 10.1056/NEJMoa1507643. Epub 2015 Sep 27. N Engl J Med. 2015. PMID: 26412456 Free PMC article. Clinical Trial.
[Lung cancer. Epidemiology, diagnosis and treatment].
Arrieta O, Lazcano E. Arrieta O, et al. Salud Publica Mex. 2019 May-Jun;61(3):217-218. doi: 10.21149/10660. Salud Publica Mex. 2019. PMID: 31276336 Spanish. No abstract available.
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.
Garon EB, Ciuleanu TE, Arrieta O, Prabhash K, Syrigos KN, Goksel T, Park K, Gorbunova V, Kowalyszyn RD, Pikiel J, Czyzewicz G, Orlov SV, Lewanski CR, Thomas M, Bidoli P, Dakhil S, Gans S, Kim JH, Grigorescu A, Karaseva N, Reck M, Cappuzzo F, Alexandris E, Sashegyi A, Yurasov S, Pérol M. Garon EB, et al. Among authors: arrieta o. Lancet. 2014 Aug 23;384(9944):665-73. doi: 10.1016/S0140-6736(14)60845-X. Epub 2014 Jun 2. Lancet. 2014. PMID: 24933332 Clinical Trial.
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
Horn L, Spigel DR, Vokes EE, Holgado E, Ready N, Steins M, Poddubskaya E, Borghaei H, Felip E, Paz-Ares L, Pluzanski A, Reckamp KL, Burgio MA, Kohlhäeufl M, Waterhouse D, Barlesi F, Antonia S, Arrieta O, Fayette J, Crinò L, Rizvi N, Reck M, Hellmann MD, Geese WJ, Li A, Blackwood-Chirchir A, Healey D, Brahmer J, Eberhardt WEE. Horn L, et al. Among authors: arrieta o. J Clin Oncol. 2017 Dec 10;35(35):3924-3933. doi: 10.1200/JCO.2017.74.3062. Epub 2017 Oct 12. J Clin Oncol. 2017. PMID: 29023213 Free PMC article. Clinical Trial.
Tuberculosis and lung cancer.
Molina-Romero C, Arrieta O, Hernández-Pando R. Molina-Romero C, et al. Among authors: arrieta o. Salud Publica Mex. 2019 May-Jun;61(3):286-291. doi: 10.21149/10090. Salud Publica Mex. 2019. PMID: 31276345 Review. English.
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.
Vokes EE, Ready N, Felip E, Horn L, Burgio MA, Antonia SJ, Arén Frontera O, Gettinger S, Holgado E, Spigel D, Waterhouse D, Domine M, Garassino M, Chow LQM, Blumenschein G Jr, Barlesi F, Coudert B, Gainor J, Arrieta O, Brahmer J, Butts C, Steins M, Geese WJ, Li A, Healey D, Crinò L. Vokes EE, et al. Among authors: arrieta o. Ann Oncol. 2018 Apr 1;29(4):959-965. doi: 10.1093/annonc/mdy041. Ann Oncol. 2018. PMID: 29408986 Free article.
Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial.
Arrieta O, Barrón F, Ramírez-Tirado LA, Zatarain-Barrón ZL, Cardona AF, Díaz-García D, Yamamoto Ramos M, Mota-Vega B, Carmona A, Peralta Álvarez MP, Bautista Y, Aldaco F, Gerson R, Rolfo C, Rosell R. Arrieta O, et al. JAMA Oncol. 2020 Jun 1;6(6):856-864. doi: 10.1001/jamaoncol.2020.0409. JAMA Oncol. 2020. PMID: 32271354 Free PMC article. Clinical Trial.
Novel molecular targets for the treatment of lung cancer.
Rosell R, Karachaliou N, Arrieta O. Rosell R, et al. Among authors: arrieta o. Curr Opin Oncol. 2020 Jan;32(1):37-43. doi: 10.1097/CCO.0000000000000590. Curr Opin Oncol. 2020. PMID: 31599770 Review.
Recomendaciones para la prescripción segura de opioides en el manejo del dolor crónico no oncológico.
Verástegui E, Plancarte R, Domínguez J, Burgos R, Arrieta O, Campillo C, Celis MÁ, la-Llata M, Halabe J, Islas S, Jasso L, Lifshitz A, Moreno M, Reyes A, Ruiz-Argüelles G, Soda A, Sotelo J. Verástegui E, et al. Among authors: arrieta o. Gac Med Mex. 2018;154(4):532-533. doi: 10.24875/GMM.18003760. Gac Med Mex. 2018. PMID: 30250317 Free article.
260 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page